At Food Ingredients Europe 2017, innovative IPH peptide complexes developed by IDEAL PHARMA PEPTIDE were prominently showcased by its official representatives, Fingres BIOTECH Inc. and Fingres Ingredients, Quality & Technology. The exhibition took place in Frankfurt am Main, Germany, from November 28 to 30, 2017, with the company’s booth number 09.0A70.
The international event, a significant conference and exhibition on food additives, ingredients, and quality control, gathered over 1,400 companies from around the globe. These companies specialize in the supply and production of food additives, components, natural, and organic products, with a consistent focus on sports nutrition.
The innovative IPH amino acid-peptide complexes, developed by specialists from IDEAL PHARMA PEPTIDE in Germany, were introduced to the Southeast Asian market by Fingres Ingredients, Quality & Technology, alongside Fingres BIOTECH Inc. Fingres represents IDEAL PHARMA PEPTIDE’s interests across Vietnam, Cambodia, Laos, Myanmar, Thailand, Malaysia, Indonesia, and the Philippines, offering a wide range of ingredients for the food, sports, and pharmaceutical industries.
Following the exhibition, IDEAL PHARMA PEPTIDE concluded further agreements with FINGRES BIOTECH Inc. for the cooperation and distribution of the new IPH amino acid peptide complexes in Southeast Asia. Ideal Pharma Peptide, an innovative European company, leverages proprietary technologies and short peptides to develop IPH peptide complexes such as BCAA IPH AGAA, BCAA IPH AVN, and BCAA IPH AEN.
